Prognostic pathways in early-stage ovarian cancer: can gene expression transcend histological subtype?
Ann Oncol
.
2016 Aug;27(8):1366-8.
doi: 10.1093/annonc/mdw254.
Epub 2016 Jun 29.
Author
I A McNeish
1
Affiliation
1
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
[email protected]
.
PMID:
27358384
DOI:
10.1093/annonc/mdw254
No abstract available
Publication types
Editorial
MeSH terms
Biomarkers, Tumor / genetics
Female
Gene Expression Regulation, Neoplastic*
Humans
Neoplasm Staging
Ovarian Neoplasms / diagnosis*
Ovarian Neoplasms / genetics*
Ovarian Neoplasms / therapy
Prognosis
Substances
Biomarkers, Tumor
Grants and funding
G0501974/MRC_/Medical Research Council/United Kingdom